{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T14:49:47Z","timestamp":1775227787431,"version":"3.50.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K07350"],"award-info":[{"award-number":["22K07350"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21H05049"],"award-info":[{"award-number":["21H05049"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016923","name":"Hoansha Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"DOI":"10.1186\/s12974-026-03734-1","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:56:05Z","timestamp":1772168165000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Microglia\u2013T cell interactions drive \u03b1-synuclein pathology in a Parkinson\u2019s disease mouse model"],"prefix":"10.1186","volume":"23","author":[{"given":"Yosuke","family":"Ohtake","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nana","family":"Norikami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoka","family":"Manabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahide","family":"Itokazu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihide","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"key":"3734_CR1","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, et al. Parkinson disease. Nat Rev Dis Primers. 2017;3:17013.","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"3734_CR2","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1056\/NEJMra2401857","volume":"391","author":"CM Tanner","year":"2024","unstructured":"Tanner CM, Ostrem JL. Parkinson\u2019s disease. N Engl J Med. 2024;391(5):442\u201352.","journal-title":"N Engl J Med"},{"issue":"3","key":"3734_CR3","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41419-023-05672-9","volume":"14","author":"P Calabresi","year":"2023","unstructured":"Calabresi P, et al. Alpha-synuclein in parkinson\u2019s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction. Cell Death Dis. 2023;14(3):176.","journal-title":"Cell Death Dis"},{"key":"3734_CR4","doi-asserted-by":"publisher","first-page":"736978","DOI":"10.3389\/fmed.2021.736978","volume":"8","author":"E Srinivasan","year":"2021","unstructured":"Srinivasan E, et al. Alpha-Synuclein aggregation in parkinson\u2019s disease. Front Med (Lausanne). 2021;8:736978.","journal-title":"Front Med (Lausanne)"},{"issue":"s1","key":"3734_CR5","doi-asserted-by":"publisher","first-page":"S105","DOI":"10.3233\/JPD-223237","volume":"12","author":"N Stefanova","year":"2022","unstructured":"Stefanova N. Microglia in parkinson\u2019s disease. J Parkinsons Dis. 2022;12(s1):S105\u201312.","journal-title":"J Parkinsons Dis"},{"issue":"11","key":"3734_CR6","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey MG, et al. Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol. 2022;22(11):657\u201373.","journal-title":"Nat Rev Immunol"},{"key":"3734_CR7","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3389\/fncel.2018.00247","volume":"12","author":"SA Ferreira","year":"2018","unstructured":"Ferreira SA, Romero-Ramos M. Microglia response during parkinson\u2019s disease: Alpha-Synuclein intervention. Front Cell Neurosci. 2018;12:247.","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"3734_CR8","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13024-017-0222-8","volume":"12","author":"A Sommer","year":"2017","unstructured":"Sommer A, Winner B, Prots I. The Trojan horse - neuroinflammatory impact of T cells in neurodegenerative diseases. Mol Neurodegener. 2017;12(1):78.","journal-title":"Mol Neurodegener"},{"issue":"6","key":"3734_CR9","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41582-020-0344-4","volume":"16","author":"EK Tan","year":"2020","unstructured":"Tan EK, et al. Parkinson disease and the immune system - associations, mechanisms and therapeutics. Nat Rev Neurol. 2020;16(6):303\u201318.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"3734_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12974-023-02723-y","volume":"20","author":"Y Xu","year":"2023","unstructured":"Xu Y, et al. The reciprocal interactions between microglia and T cells in parkinson\u2019s disease: a double-edged sword. J Neuroinflammation. 2023;20(1):33.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"3734_CR11","first-page":"182","volume":"119","author":"V Brochard","year":"2009","unstructured":"Brochard V, et al. Infiltration of CD4\u2009+\u2009lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J Clin Invest. 2009;119(1):182\u201392.","journal-title":"J Clin Invest"},{"issue":"23","key":"3734_CR12","doi-asserted-by":"publisher","first-page":"9592","DOI":"10.1523\/JNEUROSCI.5610-12.2013","volume":"33","author":"AS Harms","year":"2013","unstructured":"Harms AS, et al. MHCII is required for alpha-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration. J Neurosci. 2013;33(23):9592\u2013600.","journal-title":"J Neurosci"},{"issue":"1","key":"3734_CR13","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s12974-020-01911-4","volume":"17","author":"MS Subbarayan","year":"2020","unstructured":"Subbarayan MS, et al. T cell infiltration and upregulation of MHCII in microglia leads to accelerated neuronal loss in an alpha-synuclein rat model of parkinson\u2019s disease. J Neuroinflammation. 2020;17(1):242.","journal-title":"J Neuroinflammation"},{"issue":"7","key":"3734_CR14","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1093\/brain\/awab103","volume":"144","author":"GP Williams","year":"2021","unstructured":"Williams GP, et al. CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of parkinson\u2019s disease. Brain. 2021;144(7):2047\u201359.","journal-title":"Brain"},{"issue":"5","key":"3734_CR15","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s00401-020-02126-w","volume":"139","author":"GP Williams","year":"2020","unstructured":"Williams GP, et al. T cell infiltration in both human multiple system atrophy and a novel mouse model of the disease. Acta Neuropathol. 2020;139(5):855\u201374.","journal-title":"Acta Neuropathol"},{"issue":"39","key":"3734_CR16","doi-asserted-by":"publisher","first-page":"E8284","DOI":"10.1073\/pnas.1710442114","volume":"114","author":"P Thakur","year":"2017","unstructured":"Thakur P, et al. Modeling parkinson\u2019s disease pathology by combination of fibril seeds and alpha-synuclein overexpression in the rat brain. Proc Natl Acad Sci U S A. 2017;114(39):E8284\u201393.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"3734_CR17","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.3233\/JPD-223452","volume":"12","author":"A Bjorklund","year":"2022","unstructured":"Bjorklund A, et al. A combined alpha-Synuclein\/Fibril (SynFib) model of Parkinson-Like synucleinopathy targeting the nigrostriatal dopamine system. J Parkinsons Dis. 2022;12(8):2307\u201320.","journal-title":"J Parkinsons Dis"},{"issue":"1","key":"3734_CR18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/intimm\/14.1.87","volume":"14","author":"R Ceredig","year":"2002","unstructured":"Ceredig R. The ontogeny of B cells in the thymus of normal, CD3 epsilon knockout (KO), RAG-2 KO and IL-7 Transgenic mice. Int Immunol. 2002;14(1):87\u201399.","journal-title":"Int Immunol"},{"issue":"1","key":"3734_CR19","doi-asserted-by":"publisher","first-page":"88","DOI":"10.4049\/jimmunol.162.1.88","volume":"162","author":"B Wang","year":"1999","unstructured":"Wang B, et al. T lymphocyte development in the absence of CD3 epsilon or CD3 gamma delta epsilon zeta. J Immunol. 1999;162(1):88\u201394.","journal-title":"J Immunol"},{"key":"3734_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40478-015-0185-3","volume":"3","author":"T Stewart","year":"2015","unstructured":"Stewart T, et al. Phosphorylated alpha-synuclein in parkinson\u2019s disease: correlation depends on disease severity. Acta Neuropathol Commun. 2015;3:7.","journal-title":"Acta Neuropathol Commun"},{"issue":"121","key":"3734_CR21","doi-asserted-by":"publisher","first-page":"121ra20","DOI":"10.1126\/scitranslmed.3002566","volume":"4","author":"Y Wang","year":"2012","unstructured":"Wang Y, et al. Phosphorylated alpha-synuclein in parkinson\u2019s disease. Sci Transl Med. 2012;4(121):121ra20.","journal-title":"Sci Transl Med"},{"key":"3734_CR22","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3389\/fneur.2019.00122","volume":"10","author":"E Caggiu","year":"2019","unstructured":"Caggiu E, et al. Inflammation, infectious Triggers, and parkinson\u2019s disease. Front Neurol. 2019;10:122.","journal-title":"Front Neurol"},{"key":"3734_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.parkreldis.2019.05.040","volume":"65","author":"Y Compta","year":"2019","unstructured":"Compta Y, et al. Cerebrospinal fluid cytokines in multiple system atrophy: A cross-sectional Catalan MSA registry study. Parkinsonism Relat Disord. 2019;65:3\u201312.","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"3734_CR24","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/glia.24295","volume":"71","author":"L Basurco","year":"2023","unstructured":"Basurco L, et al. Microglia and astrocyte activation is region-dependent in the alpha-synuclein mouse model of parkinson\u2019s disease. Glia. 2023;71(3):571\u201387.","journal-title":"Glia"},{"issue":"1","key":"3734_CR25","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12974-021-02158-3","volume":"18","author":"J Rostami","year":"2021","unstructured":"Rostami J, et al. Crosstalk between astrocytes and microglia results in increased degradation of alpha-synuclein and amyloid-beta aggregates. J Neuroinflammation. 2021;18(1):124.","journal-title":"J Neuroinflammation"},{"key":"3734_CR26","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3389\/fnmol.2018.00144","volume":"11","author":"E Janda","year":"2018","unstructured":"Janda E, Boi L, Carta AR. Microglial phagocytosis and its regulation: A therapeutic target in parkinson\u2019s disease? Front Mol Neurosci. 2018;11:144.","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"3734_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.55782\/ane-1999-1289","volume":"59","author":"I Kurkowska-Jastrzebska","year":"1999","unstructured":"Kurkowska-Jastrzebska I, et al. MHC class II positive microglia and lymphocytic infiltration are present in the substantia Nigra and striatum in mouse model of parkinson\u2019s disease. Acta Neurobiol Exp (Wars). 1999;59(1):1\u20138.","journal-title":"Acta Neurobiol Exp (Wars)"},{"issue":"4","key":"3734_CR28","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1002\/(SICI)1521-4141(199904)29:04<1275::AID-IMMU1275>3.0.CO;2-T","volume":"29","author":"GM O\u2019Keefe","year":"1999","unstructured":"O\u2019Keefe GM, Nguyen VT, Benveniste EN. Class II transactivator and class II MHC gene expression in microglia: modulation by the cytokines TGF-beta, IL-4, IL-13 and IL-10. Eur J Immunol. 1999;29(4):1275\u201385.","journal-title":"Eur J Immunol"},{"issue":"2","key":"3734_CR29","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.neuron.2014.02.040","volume":"82","author":"MR Elmore","year":"2014","unstructured":"Elmore MR, et al. Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain. Neuron. 2014;82(2):380\u201397.","journal-title":"Neuron"},{"issue":"8","key":"3734_CR30","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","volume":"38","author":"PL McGeer","year":"1988","unstructured":"McGeer PL, et al. Reactive microglia are positive for HLA-DR in the substantia Nigra of parkinson\u2019s and alzheimer\u2019s disease brains. Neurology. 1988;38(8):1285\u201391.","journal-title":"Neurology"},{"issue":"1","key":"3734_CR31","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12883-019-1286-6","volume":"19","author":"D Rathnayake","year":"2019","unstructured":"Rathnayake D, Chang T, Udagama P. Selected serum cytokines and nitric oxide as potential multi-marker biosignature panels for Parkinson disease of varying durations: a case-control study. BMC Neurol. 2019;19(1):56.","journal-title":"BMC Neurol"},{"issue":"1","key":"3734_CR32","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.stem.2018.06.015","volume":"23","author":"A Sommer","year":"2018","unstructured":"Sommer A, et al. Th17 lymphocytes induce neuronal cell death in a human iPSC-Based model of parkinson\u2019s disease. Cell Stem Cell. 2018;23(1):123\u2013e1316.","journal-title":"Cell Stem Cell"},{"issue":"7660","key":"3734_CR33","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nature22815","volume":"546","author":"D Sulzer","year":"2017","unstructured":"Sulzer D, et al. T cells from patients with parkinson\u2019s disease recognize alpha-synuclein peptides. Nature. 2017;546(7660):656\u201361.","journal-title":"Nature"},{"issue":"1","key":"3734_CR34","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/s41598-020-79726-9","volume":"11","author":"A Singhania","year":"2021","unstructured":"Singhania A, et al. The TCR repertoire of alpha-synuclein-specific T cells in parkinson\u2019s disease is surprisingly diverse. Sci Rep. 2021;11(1):302.","journal-title":"Sci Rep"},{"issue":"7970","key":"3734_CR35","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/s41586-023-06300-4","volume":"619","author":"TY Park","year":"2023","unstructured":"Park TY, et al. Co-transplantation of autologous T(reg) cells in a cell therapy for parkinson\u2019s disease. Nature. 2023;619(7970):606\u201315.","journal-title":"Nature"},{"issue":"4","key":"3734_CR36","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.jaci.2024.02.003","volume":"153","author":"SK Wyatt-Johnson","year":"2024","unstructured":"Wyatt-Johnson SK, Afify R, Brutkiewicz RR. The immune system in neurological diseases: what innate-like T cells have to say. J Allergy Clin Immunol. 2024;153(4):913\u201323.","journal-title":"J Allergy Clin Immunol"},{"key":"3734_CR37","doi-asserted-by":"publisher","first-page":"104928","DOI":"10.1016\/j.cellimm.2025.104928","volume":"409\u2013410","author":"D Daneshjou","year":"2025","unstructured":"Daneshjou D, et al. The double-edged sword role of natural killer cells in parkinson\u2019s disease. Cell Immunol. 2025;409\u2013410:104928.","journal-title":"Cell Immunol"},{"key":"3734_CR38","doi-asserted-by":"publisher","first-page":"890816","DOI":"10.3389\/fnagi.2022.890816","volume":"14","author":"L Zhang","year":"2022","unstructured":"Zhang L, Zhang Y, Fan D. Pathological role of natural killer cells in parkinson\u2019s disease: A systematic review. Front Aging Neurosci. 2022;14:890816.","journal-title":"Front Aging Neurosci"},{"key":"3734_CR39","doi-asserted-by":"publisher","first-page":"p4807179","DOI":"10.1155\/2020\/4807179","volume":"2020","author":"P Ugalde-Muniz","year":"2020","unstructured":"Ugalde-Muniz P, et al. Chronic systemic inflammation exacerbates neurotoxicity in a parkinson\u2019s disease model. Oxid Med Cell Longev. 2020;2020:p4807179.","journal-title":"Oxid Med Cell Longev"},{"issue":"2","key":"3734_CR40","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41419-021-03469-2","volume":"12","author":"W Oda","year":"2021","unstructured":"Oda W, et al. Inhibition of repulsive guidance molecule-a protects dopaminergic neurons in a mouse model of parkinson\u2019s disease. Cell Death Dis. 2021;12(2):181.","journal-title":"Cell Death Dis"},{"issue":"3","key":"3734_CR41","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1080\/25785826.2018.1531190","volume":"41","author":"F Shimizu","year":"2018","unstructured":"Shimizu F, Nishihara H, Kanda T. Blood-brain barrier dysfunction in immuno-mediated neurological diseases. Immunol Med. 2018;41(3):120\u20138.","journal-title":"Immunol Med"},{"issue":"10","key":"3734_CR42","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1016\/j.cell.2024.04.005","volume":"187","author":"X Liu","year":"2024","unstructured":"Liu X, et al. Small-molecule-induced epigenetic rejuvenation promotes SREBP condensation and overcomes barriers to CNS Myelin regeneration. Cell. 2024;187(10):2465\u2013e248422.","journal-title":"Cell"},{"issue":"Suppl 1","key":"3734_CR43","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/jnc.13062","volume":"136","author":"Z Chen","year":"2016","unstructured":"Chen Z, Trapp BD. Microglia and neuroprotection. J Neurochem. 2016;136(Suppl 1):10\u20137.","journal-title":"J Neurochem"},{"issue":"1","key":"3734_CR44","doi-asserted-by":"publisher","first-page":"NS20200024","DOI":"10.1042\/NS20200024","volume":"5","author":"Y Fujita","year":"2021","unstructured":"Fujita Y, Yamashita T. Neuroprotective function of microglia in the developing brain. Neuronal Signal. 2021;5(1):NS20200024.","journal-title":"Neuronal Signal"},{"key":"3734_CR45","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/978-981-13-9913-8_13","volume":"1175","author":"MS Ho","year":"2019","unstructured":"Ho MS. Microglia in parkinson\u2019s disease. Adv Exp Med Biol. 2019;1175:335\u201353.","journal-title":"Adv Exp Med Biol"},{"key":"3734_CR46","doi-asserted-by":"crossref","unstructured":"IsikS et al. Microglia Mediated Neuroinflammation in Parkinson\u2019s Disease. Cells. 2023;12(7). https:\/\/pubmed.ncbi.nlm.nih.gov\/37048085\/.","DOI":"10.3390\/cells12071012"},{"issue":"7953","key":"3734_CR47","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/d41586-023-00600-5","volume":"615","author":"IH Guldner","year":"2023","unstructured":"Guldner IH, Wyss-Coray T. Activated immune cells drive neurodegeneration in an alzheimer\u2019s model. Nature. 2023;615(7953):588\u20139.","journal-title":"Nature"},{"issue":"7953","key":"3734_CR48","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/s41586-023-05788-0","volume":"615","author":"X Chen","year":"2023","unstructured":"Chen X, et al. Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy. Nature. 2023;615(7953):668\u201377.","journal-title":"Nature"},{"issue":"1","key":"3734_CR49","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1186\/s12974-018-1348-5","volume":"15","author":"RE Bennett","year":"2018","unstructured":"Bennett RE, et al. Partial reduction of microglia does not affect Tau pathology in aged mice. J Neuroinflammation. 2018;15(1):311.","journal-title":"J Neuroinflammation"},{"issue":"2","key":"3734_CR50","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/glia.23529","volume":"67","author":"J Han","year":"2019","unstructured":"Han J, et al. Enforced microglial depletion and repopulation as a promising strategy for the treatment of neurological disorders. Glia. 2019;67(2):217\u201331.","journal-title":"Glia"},{"key":"3734_CR51","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.brainresbull.2019.05.020","volume":"152","author":"JQ Liu","year":"2019","unstructured":"Liu JQ, et al. Role of chemokines in parkinson\u2019s disease. Brain Res Bull. 2019;152:11\u20138.","journal-title":"Brain Res Bull"},{"issue":"12","key":"3734_CR52","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.4049\/jimmunol.1800587","volume":"202","author":"S Mondal","year":"2019","unstructured":"Mondal S, et al. Low-Dose Maraviroc, an antiretroviral Drug, attenuates the infiltration of T cells into the central nervous system and protects the nigrostriatum in Hemiparkinsonian monkeys. J Immunol. 2019;202(12):3412\u201322.","journal-title":"J Immunol"},{"issue":"5","key":"3734_CR53","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.neuron.2022.12.009","volume":"111","author":"Z Shi","year":"2023","unstructured":"Shi Z, et al. Microglia drive transient insult-induced brain injury by chemotactic recruitment of CD8(+) T lymphocytes. Neuron. 2023;111(5):696\u2013e7109.","journal-title":"Neuron"},{"issue":"5","key":"3734_CR54","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.neuron.2023.02.005","volume":"111","author":"R Kumari","year":"2023","unstructured":"Kumari R, Gensel JC. Microglia as drivers of neurodegeneration: the role of innate-adaptive immune signaling. Neuron. 2023;111(5):597\u20138.","journal-title":"Neuron"},{"issue":"6411","key":"3734_CR55","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1126\/science.aat0474","volume":"362","author":"MS Thion","year":"2018","unstructured":"Thion MS, Ginhoux F, Garel S. Microglia and early brain development: an intimate journey. Science. 2018;362(6411):185\u20139.","journal-title":"Science"},{"issue":"12","key":"3734_CR56","doi-asserted-by":"publisher","first-page":"3501","DOI":"10.1016\/j.celrep.2018.05.048","volume":"23","author":"A Villa","year":"2018","unstructured":"Villa A, et al. Sex-Specific features of microglia from adult mice. Cell Rep. 2018;23(12):3501\u201311.","journal-title":"Cell Rep"},{"key":"3734_CR57","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.bbi.2025.06.026","volume":"129","author":"CJ Kaufhold","year":"2025","unstructured":"Kaufhold CJ, et al. Sex differences in neurological disorders: insights from ischemic stroke, parkinson\u2019s disease, and multiple sclerosis. Brain Behav Immun. 2025;129:335\u201347.","journal-title":"Brain Behav Immun"},{"issue":"1","key":"3734_CR58","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13293-025-00692-w","volume":"16","author":"SL Schaffner","year":"2025","unstructured":"Schaffner SL, et al. Sex and gender differences in the molecular etiology of parkinson\u2019s disease: considerations for study design and data analysis. Biol Sex Differ. 2025;16(1):7.","journal-title":"Biol Sex Differ"},{"key":"3734_CR59","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.nbd.2015.06.003","volume":"82","author":"KL Paumier","year":"2015","unstructured":"Paumier KL, et al. Intrastriatal injection of pre-formed mouse alpha-synuclein fibrils into rats triggers alpha-synuclein pathology and bilateral nigrostriatal degeneration. Neurobiol Dis. 2015;82:185\u201399.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"3734_CR60","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/ejn.16196","volume":"59","author":"A Singh","year":"2024","unstructured":"Singh A, et al. Combining fibril-induced alpha-synuclein aggregation and 6-hydroxydopamine in a mouse model of parkinson\u2019s disease and the effect of cerebral dopamine neurotrophic factor on the induced neurodegeneration. Eur J Neurosci. 2024;59(1):132\u201353.","journal-title":"Eur J Neurosci"},{"issue":"9","key":"3734_CR61","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1038\/nprot.2014.143","volume":"9","author":"LA Volpicelli-Daley","year":"2014","unstructured":"Volpicelli-Daley LA, Luk KC, Lee VM. Addition of exogenous alpha-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous alpha-synuclein to lewy body and lewy neurite-like aggregates. Nat Protoc. 2014;9(9):2135\u201346.","journal-title":"Nat Protoc"},{"issue":"2","key":"3734_CR62","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3233\/JPD-171248","volume":"8","author":"NK Polinski","year":"2018","unstructured":"Polinski NK, et al. Best practices for generating and using Alpha-Synuclein Pre-Formed fibrils to model parkinson\u2019s disease in rodents. J Parkinsons Dis. 2018;8(2):303\u201322.","journal-title":"J Parkinsons Dis"},{"key":"3734_CR63","doi-asserted-by":"crossref","unstructured":"PattersonJR et al. Generation of Alpha-Synuclein preformed fibrils from monomers and use in vivo. J Vis Exp. 2019;(148). https:\/\/pubmed.ncbi.nlm.nih.gov\/31205308\/.","DOI":"10.3791\/59758"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-026-03734-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03734-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03734-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T14:03:49Z","timestamp":1775225029000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12974-026-03734-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3734"],"URL":"https:\/\/doi.org\/10.1186\/s12974-026-03734-1","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]},"assertion":[{"value":"4 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures, breeding, and housing were conducted in accordance with the guidelines for Animal Care of Osaka University and were approved by the Care and Use of Laboratory Animals Committee of Osaka University Graduate School of Medicine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and approved the final manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"110"}}